2 weeks Ago By ABMN Staff
Alignment Healthcare, Inc. ( NASDAQ:ALHC – Get Free Report ) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 4,750,000 shares, a growth of 6.
0% from the August 31st total of 4,480,000 shares. Based on an average daily volume of 1,050,000 shares, the short-interest ratio is currently 4.5 days.
Approximately 5.5% of the shares of the company are sold short. Analyst Ratings Changes ALHC has been the topic of several research reports.
Stifel Nicolaus boosted their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “buy” rating in a report on Friday, July 26th.
Robert W. Baird increased their price objective on shares of Alignment Healthcare from $10.00 to $11.
00 and gave the company an “outperform” rating in a report on Wednesday, August 14th. TD Cowen upped their target price on shares of Alignment Healthcare from $8.00 to $10.
00 and gave the company a “buy” rating in a research note on Tuesday, August 6th. Piper Sandler reaffirmed an “overweight” rating and issued a $10.00 target price (up previously from $8.
00) on shares of Alignment Healthcare in a research report on Tuesday, August 6th. Finally, Barclays lifted their price objective on shares of Alignment Healthcare from $4.50 to $7.
00 and gave the company an “underweight” rating in a research report on Monday, August 5th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $9.
83. View Our Latest Stock Report on ALHC Insiders Place Their Bets Institutional Investors Weigh In On Alignment Healthcare Several large investors have recently added to or reduced their stakes in ALHC. Jacobs Levy Equity Management Inc.
purchased a new position in Alignment Healthcare during the 1st quarter worth $918,000. Vanguard Group Inc. lifted its stake in shares of Alignment Healthcare by 1.
0% during the first quarter. Vanguard Group Inc. now owns 9,239,472 shares of the company’s stock valued at $45,828,000 after buying an additional 93,262 shares during the period.
Deerfield Management Company L.P. Series C lifted its stake in shares of Alignment Healthcare by 31.
8% during the second quarter. Deerfield Management Company L.P.
Series C now owns 10,901,485 shares of the company’s stock valued at $85,250,000 after buying an additional 2,630,788 shares during the period. Bank of New York Mellon Corp increased its position in Alignment Healthcare by 27.5% during the second quarter.
Bank of New York Mellon Corp now owns 382,462 shares of the company’s stock worth $2,991,000 after purchasing an additional 82,559 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in Alignment Healthcare by 1.
4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 751,309 shares of the company’s stock worth $6,469,000 after purchasing an additional 10,123 shares during the last quarter.
86.19% of the stock is owned by hedge funds and other institutional investors. Alignment Healthcare Price Performance NASDAQ:ALHC opened at $11.
82 on Tuesday. The company has a debt-to-equity ratio of 1.70, a current ratio of 1.
61 and a quick ratio of 1.61. The business has a 50 day simple moving average of $9.
65 and a 200-day simple moving average of $7.75. Alignment Healthcare has a 1 year low of $4.
46 and a 1 year high of $12.36. The firm has a market capitalization of $2.
26 billion, a price-to-earnings ratio of -14.07 and a beta of 1.43.
Alignment Healthcare ( NASDAQ:ALHC – Get Free Report ) last released its quarterly earnings data on Thursday, August 1st. The company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.
14) by $0.01. Alignment Healthcare had a negative return on equity of 101.
10% and a negative net margin of 6.85%. The business had revenue of $681.
29 million during the quarter, compared to analyst estimates of $637.66 million. During the same quarter last year, the business posted ($0.
15) EPS. The company’s revenue was up 47.3% on a year-over-year basis.
Equities analysts forecast that Alignment Healthcare will post -0.67 EPS for the current year. Alignment Healthcare Company Profile ( Get Free Report ) Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States.
It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California. Recommended Stories Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.
com's FREE daily email newsletter ..
